These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
297 related items for PubMed ID: 16815535
1. Association between cigarette smoking and prognosis in locally advanced cervical carcinoma treated with chemoradiation: a Gynecologic Oncology Group study. Waggoner SE, Darcy KM, Fuhrman B, Parham G, Lucci J, Monk BJ, Moore DH, Gynecologic Oncology Group. Gynecol Oncol; 2006 Dec; 103(3):853-8. PubMed ID: 16815535 [Abstract] [Full Text] [Related]
2. Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma. Farley JH, Hickey KW, Carlson JW, Rose GS, Kost ER, Harrison TA. Cancer; 2003 May 01; 97(9):2196-202. PubMed ID: 12712471 [Abstract] [Full Text] [Related]
3. Smoking behavior in women with locally advanced cervical carcinoma: a Gynecologic Oncology Group study. Waggoner SE, Darcy KM, Tian C, Lanciano R. Am J Obstet Gynecol; 2010 Mar 01; 202(3):283.e1-7. PubMed ID: 20044066 [Abstract] [Full Text] [Related]
4. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer. Gatcliffe TA, Tewari KS, Shah A, Brewster WR, Burger RA, Kuo JV, Monk BJ. Gynecol Oncol; 2009 Jan 01; 112(1):85-9. PubMed ID: 18977518 [Abstract] [Full Text] [Related]
5. Glucose as a prognostic factor in non-diabetic women with locally advanced cervical cancer (IIB-IVA). Lee YY, Choi CH, Kim CJ, Song TJ, Kim MK, Kim TJ, Lee JW, Kim BG, Lee JH, Bae DS. Gynecol Oncol; 2010 Mar 01; 116(3):459-63. PubMed ID: 20004008 [Abstract] [Full Text] [Related]
6. A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study. Rotman M, Sedlis A, Piedmonte MR, Bundy B, Lentz SS, Muderspach LI, Zaino RJ. Int J Radiat Oncol Biol Phys; 2006 May 01; 65(1):169-76. PubMed ID: 16427212 [Abstract] [Full Text] [Related]
7. Para-aortic involvement and interest of para-aortic lymphadenectomy after chemoradiation therapy in patients with stage IB2 and II cervical carcinoma radiologically confined to the pelvic cavity. Delpech Y, Haie-Meder C, Rey A, Zafrani Y, Uzan C, Gouy S, Pautier P, Lhommé C, Duvillard P, Castaigne D, Morice P. Ann Surg Oncol; 2007 Nov 01; 14(11):3223-31. PubMed ID: 17713822 [Abstract] [Full Text] [Related]
8. RTOG 0417: efficacy of bevacizumab in combination with definitive radiation therapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma. Schefter T, Winter K, Kwon JS, Stuhr K, Balaraj K, Yaremko BP, Small W, Sause W, Gaffney D, Radiation Therapy Oncology Group (RTOG). Int J Radiat Oncol Biol Phys; 2014 Jan 01; 88(1):101-5. PubMed ID: 24331655 [Abstract] [Full Text] [Related]
9. [Cervical cancer in the young woman]. Marie G, Barjot P, Crouet H, Mace-Lesech J, Dommesent D, Uzan M. J Gynecol Obstet Biol Reprod (Paris); 1993 Jan 01; 22(7):743-7. PubMed ID: 8308200 [Abstract] [Full Text] [Related]
10. Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients. Khuri FR, Lee JJ, Lippman SM, Kim ES, Cooper JS, Benner SE, Winn R, Pajak TF, Williams B, Shenouda G, Hodson I, Fu K, Shin DM, Vokes EE, Feng L, Goepfert H, Hong WK. J Natl Cancer Inst; 2006 Apr 05; 98(7):441-50. PubMed ID: 16595780 [Abstract] [Full Text] [Related]
11. [Cervical adenocarcinomas: diagnostic, prognostic and therapeutic aspects in a 49 case-control study]. Martel P, Connan L, Bonnet F, Delannes M, Farnarier J, Mihura J, El Ghaoui A. J Gynecol Obstet Biol Reprod (Paris); 2000 Feb 05; 29(1):48-54. PubMed ID: 10675833 [Abstract] [Full Text] [Related]
12. [Lung cancer in women: clinical features and factors related to survival]. Sen E, Kaya A, Erol S, Savas I, Gonullu U. Tuberk Toraks; 2008 Feb 05; 56(3):266-74. PubMed ID: 18932027 [Abstract] [Full Text] [Related]
13. Tumor vascularity--a novel prognostic factor in advanced cervical carcinoma. Schlenger K, Höckel M, Mitze M, Schäffer U, Weikel W, Knapstein PG, Lambert A. Gynecol Oncol; 1995 Oct 05; 59(1):57-66. PubMed ID: 7557616 [Abstract] [Full Text] [Related]
14. Multimodal treatment of locally advanced cervical cancer. Dueñas-González A, Cetina-Pérez L, Oñate-Ocaña LF, Rivera L, Lopez-Graniel C, González-Enciso A, Candelaria M, Mohar A. Arch Med Res; 2005 Oct 05; 36(2):129-35. PubMed ID: 15847945 [Abstract] [Full Text] [Related]
15. Clinicopathologic factors for central recurrence in patients with locally advanced bulky cervical cancer. Lee WM, Park SI, Kim BJ, Kim MH, Choi SC, Lee ED, Ryu SY. Eur J Obstet Gynecol Reprod Biol; 2012 Apr 05; 161(2):219-23. PubMed ID: 22326616 [Abstract] [Full Text] [Related]
16. [Adenocarcinoma of the uterine cervix]. Inoue Y, Noda K. Gan No Rinsho; 1989 Oct 05; 35(13):1610-4. PubMed ID: 2685397 [Abstract] [Full Text] [Related]
17. Locally advanced adenocarcinoma and adenosquamous carcinomas of the cervix compared to squamous cell carcinomas of the cervix in gynecologic oncology group trials of cisplatin-based chemoradiation. Rose PG, Java JJ, Whitney CW, Stehman FB, Lanciano R, Thomas GM. Gynecol Oncol; 2014 Nov 05; 135(2):208-12. PubMed ID: 25152438 [Abstract] [Full Text] [Related]
18. Impact of previous tracheotomy as a prognostic factor in patients with locally advanced squamous cell carcinoma of the larynx submitted to concomitant chemotherapy and radiation. Herchenhorn D, Dias FL, Ferreira CG, Araújo CM, Lima RA, Small IA, Kligerman J. ORL J Otorhinolaryngol Relat Spec; 2008 Nov 05; 70(6):381-8. PubMed ID: 18984974 [Abstract] [Full Text] [Related]